Skip to content
Search

Latest Stories

British Court rejects Nirav Modi's bail plea for fifth time

A UK court on Thursday (5) rejected for the fifth time the bail plea of fugitive diamond merchant Nirav Modi, who is fighting his extradition to India on charges over the nearly $2 billion Punjab National Bank (PNB) fraud and money laundering case.

Justice Ian Dove, who presided over the bail hearing at the Royal Courts of Justice, also concluded that the 49-year-old jeweller continued to pose a risk of absconding.


This was the fifth attempt at bail by Modi, who has been lodged at Wandsworth Prison in south-west London since his arrest in March last year and is scheduled for an extradition trial between May 11 and 15.

He appeared via videolink from prison as his legal team offered a package of "stringent" bail measures, including bail security of £4 million, house arrest with a 24-hour electronic tag as well as a private security guard service and a strictly monitored access to gadgets and telephones.

"There are risks involved with this applicant and the question for the court is are those risks adequately guarded against,” noted Justice Dove.

"My central concern of a risk of absconding are not obviated by the measures presented," he ruled, adding that he was unsatisfied with the arrangements presented to the court adequately contained the risks posed in the very "substantial case" of fraud and money laundering.

The Crown Prosecution Service (CPS) barrister Nick Hearn, arguing on behalf of the Indian government, had reiterated that Modi continues to remain a flight risk and that any additional measures offered for his bail would not make a breach “impossible”.

Modi's barrister, Edward Fitzgerald, argued that an offer to pay for a security guard from a reputable crisis management company offered "house arrest with effective room arrest" at his luxury apartment at Centre Point in London.

He also sought to dismiss the CPS concern of Modi continuing to interfere with witnesses due to strictly monitored access to phones and gadgets.

While details of Modi's mental health were not discussed in open court, the court was told he suffers from depression and that his psychological condition was "deteriorating with the ever-increasing detention" since his arrest in March last year.

“There have additionally been very disturbing number of physical attacks inside prison and he was told he was being set up for extortion,” Fitzgerald added.

The judge said he had taken those factors into account but concurred with both Justice Ingrid Simler, who denied bail at the High Court last year, as well as Chief Magistrate Emma Arbuthnot, who had last refused Modi's bail in November 2019.

Modi observed Thursday's proceedings via videolink from prison and occasionally referred to some files before him.

Last week, he appeared via videolink from his prison before Judge David Robinson at the Westminster Magistrates' Court for his routine 28-day call-over remand hearing and will next appear before the magistrates' court on March 24.

Modi was arrested on March 19, 2019, on an extradition warrant executed by Scotland Yard on charges brought by the Indian government.

During subsequent hearings, Westminster Magistrates' Court was told that Modi was the "principal beneficiary" of the fraudulent issuance of letters of undertaking (LoUs) as part of a conspiracy to defraud PNB and then laundering the proceeds of crime.

(PTI)

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less